US Patent Issued to Denovamed on July 15 for "5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1H-tetrazole for the topical treatment of bacterial infections" (Canadian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,902, issued on July 15, was assigned to Denovamed Inc. (Toronto).

"5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1H-tetrazole for the topical treatment of bacterial infections" was invented by Fan Wu (Toronto), Christopher R. McMaster (Toronto) and Donald F. Weaver (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound 5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1H-tetrazole, methods for the manufacture of said compound, topical compositions comprising said compound and methods of use thereof in the topical treatment of infections caused by pathogenic bacteria at a wound site."

The patent was filed on Dec. 10, 2018, unde...